Literature DB >> 19825446

Preface: acute lymphoblastic leukemia--quo vadis?

Meir Wetzler1, Wendy Stock.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19825446     DOI： 10.1016/j.hoc.2009.08.001

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


× No keyword cloud information.
  1 in total

1.  Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL).

Authors:  Martin Mutonga; Kenji Tamura; Gregory Malnassy; Noreen Fulton; Amanda de Albuquerque; Ryuji Hamamoto; Wendy Stock; Yusuke Nakamura; Houda Alachkar
Journal:  Transl Oncol       Date:  2015-10       Impact factor: 4.243
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.